Pinnacle Wealth Management Advisory Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$344K Sell
8,057
-395
-5% -$21.4K 0.02% 381
2026
Q1
$530K Buy
8,452
+3,065
+57% +$245K 0.04% 266
2025
Q4
$514K Buy
5,387
+195
+4% +$19.1K 0.04% 266
2025
Q3
$507K Buy
5,192
+35
+0.7% +$3.63K 0.04% 228
2025
Q2
$554K Buy
5,157
+243
+5% +$24.6K 0.05% 204
2025
Q1
$496K Buy
4,914
+10
+0.2% +$1.01K 0.05% 207
2024
Q4
$438K Sell
4,904
-83
-2% -$7.31K 0.04% 219
2024
Q3
$418K Buy
4,987
+51
+1% +$4.02K 0.04% 223
2024
Q2
$380K Buy
4,936
+429
+10% +$31.4K 0.04% 233
2024
Q1
$309K Buy
4,507
+147
+3% +$9.45K 0.03% 252
2023
Q4
$252K Buy
4,360
+11
+0.3% +$587 0.03% 283
2023
Q3
$230K Sell
4,349
-191
-4% -$10K 0.03% 279
2023
Q2
$246K Buy
4,540
+89
+2% +$4.65K 0.03% 275
2023
Q1
$223K Buy
+4,451
New +$210K 0.03% 281

Other funds holding BSX

Pinnacle Wealth Management Advisory Group's BSX Position: Q2 2026 in Review

Pinnacle Wealth Management Advisory Group reduced its Boston Scientific (BSX) stake by 4.7% in Q2 2026, selling an estimated $21.4K and leaving 8,057 shares worth $344K. The position accounts for 0.02% of the portfolio, ranked #381.

Pinnacle Wealth Management Advisory Group first reported a position in BSX in Q1 2023 and has held it in 14 quarters since. The position peaked at $554K in Q2 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Pinnacle Wealth Management Advisory Group held 8,057 shares of Boston Scientific worth $344K as of Q2 2026.
  • Pinnacle Wealth Management Advisory Group sold 395 Boston Scientific shares in Q2 2026, an estimated $21.4K.
  • Boston Scientific made up 0.02% of Pinnacle Wealth Management Advisory Group's portfolio in Q2 2026, its #381 holding.
  • Pinnacle Wealth Management Advisory Group first reported a position in Boston Scientific in Q1 2023 and has held it in 14 quarters since.
  • Pinnacle Wealth Management Advisory Group's Boston Scientific position peaked at $554K in Q2 2025.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Pinnacle Wealth Management Advisory Group's 13F filing for Q2 2026, filed 5 Aug 2026.